部门简介 郑锦鸿教授：
1.D.-C. WEI1, Y. PAN2, H. WANG2, W.-J. XU2, C. CHEN2, J.-H. ZHENG2, D. CAI1. Synthesis of substituted aromatic heterocyclic sulfonyl hydrazone compounds and in vitro anti-hepatoma activity: preliminary results, European Review for Medical and Pharmacological Sciences, 2018; 22: 4720-4729
2.Weijie Xu, Ying Pan, Hong Wang, Haiyan Li , Qing Peng , Duncan Wei , Cheng Chen, Jinhong Zheng*.Synthesis and eva luation of New Pyrazoline Derivatives as Potential Anticancer Agents in HepG-2 Cell Line. Molecules, 2017, 22, 467
3.Hong Wang, Jinhong Zheng, Weijie Xu, Cheng Chen, Duncan Wei, Wenxiu Ni*, Ying Pan 1,*. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis, Molecules 2017, 22(10):1635
4.盘鹰；郑锦鸿；陈诚，中国发明专利：一种査尔酮类化合物及其制备方法和应用，专利号：ZL 201610913130.3（授权公告日：2019.10.15）
5. 盘鹰；郑锦鸿；王红，中国发明专利：一种二氢吡唑类衍生物及其制备方法和应用，专利号：ZL 201610883045.7（授权公告日：2019.7.9）
6.郑锦鸿; 盘鹰; 徐伟杰，中国发明专利：一种吡唑啉衍生物及其应用，专利号：ZL 201610312373.1（授权公告日：2019.1.8）
7.盘鹰; 郑锦鸿; 陈一村; 李庆南; 叶丹彦，中国发明专利：一种磺酰腙类衍生物、其制备方法及其抗自由基或抗肿瘤活性应用，专利号：ZL201410678661.X（授权公告日：2016.11.23）
8.盘鹰; 杨芯琦; 郑锦鸿， 中国发明专利：一种查尔酮衍生物及其应用，专利号：ZL201410149716.8（授权公告日：2016.03.02）
9.魏敦灿; 王红; 张鲁勉; 何小英; 郑锦鸿，取代呋喃醛缩苯磺酰腙化合物的合成及抗肿瘤活性研究, 汕头大学医学院学报, 2016, 29(1):1-2
10.盘鹰; 唐灵芝; 张鲁勉; 郑锦鸿，1-阿魏酰基-4-取代苄基哌嗪盐酸盐的合成及其清除羟自由基活性，中国医药工业杂志，2015, 46(2)：130-134
11.杨芯琦，张鲁勉，何小英，郑锦鸿, 1,3-二苯基丙烯醇类化合物的合成及其抗氧化作用, 汕头大学医学院学报, 2014, 27(4):203-204
12.Qinrong Wang, Xin Zhang,* Jinhong Zheng and Daojun Liu*. Self-assembled peptide nanotubes as potential nanocarriers for drug delivery, RSC Adv., 2014, 4, 25461
13.盘鹰; 王锦芝; 张鲁勉; 何小英; 郑锦鸿，负载EB病毒潜伏膜蛋白基因的树突状细胞疫苗的体内抗肿瘤免疫作用，中国药物与临床，2013, 13(7):829-832
14.盘鹰; 何小英; 张鲁勉; 郑锦鸿，人外周血来源的成熟树突状细胞的体外无血清培养，中国热带医学，2013, 13(4):417-420
15.李庆南; 叶婷君; 彭青; 蔡文峰; 张鲁勉; 何小英; 郑锦鸿，取代水杨醛缩苯磺酰腙化合物的合成和清除羟自由基能力研究，汕头大学医学院学报, 2013, 26(1):1-3
16.Ying Pan, Yicun Chen, Qingnan Li, Xiaoyu Yu, Jinzhi Wang, Jinhong Zheng*. The synthesis and eva luation of novel hydroxyl substituted chalcone analogs with in vitro anti-free radicals pharmacological activity and in vivo anti-oxidation activity in a free radical-injury alzheimer’s model. Molecules, 2013, 18:1693-1703
17.Xiaoyun Zeng, Jinhong Zheng, Chenglai Fu, Hang Su, Xiaoli Sun, Xuesi Zhang, Yingjian Hou, Yi Zhu*. A Newly Synthesized Sinapic Acid Derivative Inhibits Endothelial Activation In Vitro and In Vivo, Molecular Pharmacology, 2013; 83 (5): 1099-1108
18.Ying Pan, Yicun Chen, Xiaoyu Yu, Jinzhi Wang, Lumian Zhang, Ying He, Yu Zheng and Jinhong Zheng*. The Synthesis of a Novel Chalcone and eva luation for Anti-free Radical Activity and Antagonizing the Learning Impairments in Alzheimer's Model. Cell Physiol Biochem. 2012;29(5-6):949-95
19.Ying Zeng, Hui Li, Zhexuan Lin, Hongjun Luo, Jinhong Zheng*, Wenhong Luo*. 4-Diazomethylpyridine as a Derivatization Reagent and Its Application to the Determination of Prostaglandin E2 by LC-MS/MS. Chromatographia, 2012; 75:875–881
刘道军教授：
1. Fei Tong, Xiangyuan Tang, Xin Li, Wenquan Xia, Daojun Liu*. The effect of insulin-loaded linear poly(ethylene glycol)-brush-like poly(L-lysine) block copolymer on renal ischemia/reperfusion-induced lung injury through downregulating hypoxia-inducible factor. Int. J. Namomed. 2016, 11, 1717-1730.
2. Fei Tong, Lei Luo, Daojun Liu*. Effect of intervention in mast cell funciton before reperfusion on renal ischemia-reperfusion injury in rats. Kidney Blood Pre. Res. 2016, 41, 335-344.
3. Xiang Zeng, Li Wang, Dongling Liu, Daojun Liu*. Poly(L-lysine)-based cylindrical copolypeptides brushes as potential drug and gene carriers. Colloid Polym. Sci. 2016, 294, 1909-1920.
4. Chao Lu, Xin Li, Wenquan Xia, Siheng Lu, Hongjun Luo, Danyan Ye, Yanmei Zhang, Daojun Liu*. Poly(e-benzyloxycarbonyl-L-lysine)-grafted branched polyethyleneimine as efficient nanocarriers for indomethacin with enhanced oral bioavailability and anti-inflammatory efficacy. Acta Biomater. 2017, 49, 434-443.
5. Fei Tong, Xiangyuan Tang, Lei Luo, Xin Li, Wenquan Xia, Chao Lu, Daojun Liu*. Sustained delivery of insulin-loaded block copolymers : Potential implications on renal ischemia/reperfusion injury in diabetes mellitus. Biomed. Pharmacother. 2017, 91, 534-545.
6. Zhongjie Huang, Yicun Chen, Daojun Liu*, Zhiwei Shen, Shuping Zhong, Ganggang Shi*. Gadolinium-conjugated star-block copolymer polylysine-modified polyethlenimine as high performance T1 MR imaging blood pool contrast agents. RSC Adv. 2018, 8, 5505-5512.
7. Yukui Zheng, Miao Pan, Chao Lu, Daojun Liu*. Polypeptide-based amphiphilic brush copolymers as unimolecular micelles: synthesis, characterization, and encapsulation study. Micro Nano Lett. 2018, 13, 1329-1334.
8. Wen Zhou, Yunshan Wu, Miao Pan, Daojun Liu*, Bo Liu*. Proliferation and migration of lung cancer could be inhibited by oxymatrine through the regulation for miR-520/VEGF. Am. J. Chin. Med. 2019, 47(4), 865-878.
9. Chao Lu, Ling Jiang, Weijie Xu, Feiyuan Yu, Wenquan Xia, Miao Pan, Wen Zhou, Xin Pan, Chuanbin Wu, Daojun Liu*. Poly(ethylene glycol) crosslinked multi-armed poly(e-benzyloxycarbonyl-L-lysine)s as super-amphiphiles: Synthesis, self-assembly, and eva luation as efficient delivery systems for poorly water-soluble drugs. Colloid Surface B: Biointerf. 2019, 182, 110384.
10. Chao Lu, Guilan Quan, Ma Su, Alekhya Nimmagadda, Weidong Chen, Miao Pan, Peng Teng, Feiyuan Yu, Xi Liu, Ling Jiang, Wenyi Du, Wei Hu, Fen Yao, Xin Pan, Chuanbin Wu*, Daojun Liu*, Jianfeng Cai*. Molecular architecture and charging effects enhance the in vitro and in vivo performance of multi-arm antimicrobial agents based on star-shaped poly(L-lysine). Adv. Therap. 2019, 1900147. (cover article)
11. Miao Pan, Chao Lu, Maochao Zheng, Wen Zhou, Fuling Song, Weidong Chen, Fen Yao, Daojun
Liu*, Jianfeng Cai*. Unnatural amino acid-based star-shaped poly(L-ornithine)s as emerging long-term and biofilm-disrupting antimicrobial peptides to treat Pseudomonas aeruginosa-infected burn wounds. Adv. Healthcare Mater. 2020, 2000647.
12. Maochao Zheng, Miao Pan, Wancong Zhang, Huanchang Lin, Shenlang Wu, Chao Lu*, Shijie Tang*, Daojun Liu*, Jianfeng Cai*. Poly(a-L-lysine)-based nanomaterials for versatile biomedical applications: Current advances and perspectives. Bioactive Mater. 2021, 6, 1878-1909.
盘鹰教授：
1. 国家自然科学基金委员会，国家自然科学基金面上项目，81773729，碘化N-正丁基氟哌啶醇通过JNK调节线粒体ROS自持环路拮抗缺血再灌注心肌线粒体氧化应激，2018/01-2021/12，54万元，在研，参加
2．广东省自然科学基金委员会，广东省自然科学基金自由申请项目，2015A030313448，心肌缺血再灌注时自由基与钙稳态/钙稳态调节系统的时效关系及分子基础研究，2015/08-2018/08，10万元，已结题，参加
3. 广东省自然科学基金委员会，广东省自然科学基金团队项目，9351503102000001、潮汕地区特效中药的研制与开发，2010/10-2015/10，150万元，已结题，参加
4. 国家自然科学基金委员会，国家自然科学基金面上项目，81072633，ROS与Egr-1间信号通路探讨碘化N-正丁基氟哌啶醇抗心肌缺血再灌注损伤的分子机制，2010/08-2014/08、27万元，已结题，参加
5. 广东省自然科学基金委员会，广东省自然科学基金面上项目，10151503102000048，阿魏酸哌嗪衍生物的合成及其活性研究，2010/10-2012/10，5万元，已结题，主持
6. 国家自然科学基金委员会，国家自然科学基金面上项目，50973058，基于星形多肽的多功能化药物载体及控制释放研究，2009/10-2013/10，38万元，已结题，参加
7. Wang Q, Pan Y, Luo H, Zhang Y, Gao F, Wang J* and Jinhong Zheng*. Novel Approaches for the Solid-Phase Synthesis of Dihydroquinazoline-2(1H)-One Derivatives and Biological eva luation as Potential Anticancer Agents[J], Molecules 2022, 27(23), 8577
8. Wei D, Pan Y, Wang H, Xu W, Chen C, Zheng J*, Cai D. Synthesis of substituted aromatic heterocyclic sulfonyl hydrazone compounds and in vitro anti- hepatoma activity preliminary results, Eur Rev Med and Pharmacol Sci. 2018, 22(14), 4720-4729
9. Wang H, Zheng J, Xu W, Chen C, Wei D , Ni W, Pan Y*. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis[J], Molecules. 2017, 22(10), 1635
10. Xu W, Pan Y＋, Wang H, Li H, Peng Q, Wei D, Chen C, Zheng J.Synthesis and eva luation of New Pyrazoline Derivatives as Potential Anticancer Agents on HepG-2 Cell Line[J], Molecules. 2017, 22(3), 467
11. 陈诚，张鲁勉，盘鹰*. 硝基和氨基查尔酮衍生物合成及抗肿瘤活性，汕头大学医学院学报，2016, 29(4):204-207
12. 盘鹰，唐灵芝，张鲁勉，郑锦鸿*. 1-阿魏酰基-4-苄基哌嗪盐酸盐类似物的合成及其清除羟自由基活性，中国医药工业杂志，2015, 46(2): 130-134.
13. Pan Y#, Chen Y#, Li Q, Yu X, Wang J, Zheng J*. The synthesis and eva luation of novel hydroxyl substituted chalcone analogs with invitro anti-free radicals pharmacological activity and in vivo anti-oxidation activity in a free radical- injury Alzheimer’s model[J], Molecules. 2013,
14. Pan Y#, Chen Y#, Yu X, Wang J, Zhang L, He Y, Zheng Y, Zheng J*. The Synthesis of a Novel Chalcone and eva luation for Anti-free Radical Activity and Antagonizing the Learning Impairments
in Alzheimer’s Model[J], Cell Physiol Biochem. 2012, 29:949-958. ( Impact factor 3.415)
15. Aibin Lina, Bing Tu, Ying Pan*，et al. Synthesis and structure analysis Of 4-benzyl-1-[(2E)-3-(3-bromo-4- hydroxy-5-methoxyphenyl)prop-2- enoyl] piperazine hydrochloride[J], J. Chem. Res. 2013, 37:391-393.
16. Qinrong Wang, Ying Pan, Jinzhi Wang, et al. Synthesis and biological activities of substituted N'-benzoylhydrazone derivatives[J], African Journal of Biotechnology. 2011, 10(78):18013-18021.
17. 盘鹰，王锦芝，张鲁勉等. 负载EBV-LMP2基因的树突状细胞疫苗的体内抗肿瘤免疫作用[J], 中国药物与临床, 2013, 13(7):829-832.
18. 盘鹰，何小英, 张鲁勉等. 人外周血来源的成熟树突状细胞的体外无血清培养[J], 中国热带医学，2013,13(4):417-420.
19. 盘鹰，何小英, 张鲁勉等. 冻融人外周血树突状细胞基因疫苗体外抗肿瘤活性研究[J], 中国药物与临床, 2009, 9(12):1151-1155.
20. Ying Pan, Jinkun Zhang, Ling Zhou, et al. In vitro anti-tumor immune response induced by dendritic cells transfected with EBV-LMP2 recombinant adenovirus. Biochemical and Biophysical Research Communications, 2006, 347:551-557.
21.中国发明专利，盘鹰，郑锦鸿，陈诚. 一种査尔酮类化合物及其制备方法和应用，专利号：ZL 201610913130.3
22.中国发明专利，盘鹰，郑锦鸿，王红. 一种二氢吡唑类衍生物及其制备方法和应用，专利号：ZL 201610883045.7
23.中国发明专利，郑锦鸿，盘鹰，徐伟杰. 一种吡唑啉衍生物及其应用，专利号：ZL 201610312373.1
24.中国发明专利，盘鹰，郑锦鸿，陈一村，李庆南，叶丹彦. 一种磺酰腙类衍生物、其制备方法及其抗自由基或抗肿瘤活性应用，专利号：ZL 201410678661.X
25.中国发明专利，盘鹰，杨芯琦，郑锦鸿. 一种查尔酮衍生物及其应用，专利号：ZL 201410149716.8
26.中国发明专利，郑锦鸿, 曾小耘，盘鹰. 1-芥子酰基-4-苄基哌嗪衍生物及其制备方法及抗自由基或抗炎活性应用, 专利号：ZL 201010112900.7.
倪文秀教授：
1.Yuan-Hui Zhong, Gui-Feng Huang, Sheng-Yi Zhao, Lai-Hon Chung, Hua-Tang Zhang, Jin-Hong Zheng, Yi-Lang Yan, Wen-Xiu Ni,* and Jun He*. Easy but Efficient: Facile Approach to Molecule with Theoretically Justified Donor–Acceptor Structure for Effective Photothermal Conversion and Intravenous Photothermal Therapy. Advanced. Science, 2024, 2309068.
2.Feng-Yang Wang, Liang-Mei Yang, Shan-Shan Wang, Hui Lu, Xu-Sheng Wang, Yuan Lu, Wen-Xiu Ni,* Hong Liang, and Ke-Bin Huang*. Cycloplatinated (II) Complex Based on Isoquinoline Alkaloid Elicits Ferritinophagy-Dependent Ferroptosis in Triple-Negative Breast Cancer Cells, Journal of Medicinal Chemistry, 2024, 67, 6738−6748
3.Wan-Qiong Huang, Chuan-Xian Wang, Tao Liu, Zi-Xin Li, Chen Pan, Yun-Zhou Chen, Xin Lian, Wai-Lun Man* and Wen-Xiu Ni*. A cytotoxic nitrido-osmium(VI) complex induces caspase-mediated apoptosis in HepG2 cancer cells. Dalton Trans., 2020, 49, 17173–17182. 被选为封面文章。
4.Hong Wang, Jinhong Zheng, Weijie Xu, Cheng Chen, Duncan Wei, Wenxiu Ni* and Ying Pan*. A New Series of Cytotoxic Pyrazoline Derivatives as Potential Anticancer Agents that Induce Cell Cycle Arrest and Apoptosis. Molecules，2017，22，1635-1649.
5.Wen-Xiu Ni, Yu-Min Qiu, Mian Li, Raymond Wai-Yin Sun, Shun-Ze Zhan, Seik Weng Ng, and Dan Li*. Metallophilicity-Driven Dynamic Aggregation of a Phosphorescent Gold(I)-Silver(I) Cluster Prepared by Solution-Based and Mechanochemical Approaches. J. Am. Chem. Soc., 2014, 136, 9532-9535.
6.Wen-Xiu Ni, Mian Li, Ji Zheng, Shun-Ze Zhan, Yu-Min Qiu, Seik Weng Ng, and Dan Li*. Approaching White-Light Emission from a Phosphorescent Trinuclear Gold(I) Cluster by Modulating Its Aggregation Behavior. Angew. Chem. Int. Ed. 2013, 52, 13472. 被选为封底文章
7.Wen-Xiu Ni, Wai-Lun Man, Shek-Man Yiu, Man Ho, Myra Ting-Wai Cheung, Chi-Chiu Ko, Chi-Ming Che, Yun-Wah Lam and Tai-Chu Lau. Osmium(VI) nitrido complexes bearing azole heterocycles: a new class of antitumor agents. Chem. Sci.,2012, 3, 1582.
8.Wen-Xiu Ni, Wai-Lun Man, Myra Ting-Wai Cheung, Raymond Wai-Yin Sun, Yuan-Lan Shu, Yun-Wah Lam,* Chi-Ming Che* and Tai-Chu Lau*. Osmium(VI) complexes as a new class of potential anti-cancer agents. Chem. Commun., 2011, 47, 2140.
9.Quan Tang, Wen-Xiu Ni, (共同一作) Chi-Fai Leung, Wai-Lun Man, Kenneth King-Kwan Lau, Yun-Wah Lam, Wai-Yeung Wong, Shie-Ming Peng, Gui-Jian Liu and Tai-Chu Lau. Synthesis and antitumor activity of a series of osmium(VI) nitrido complexes bearing quinolinolato ligands. Chem. Commun., 2013, 49, 9980.
10.Wen-Xiu Ni, Mian Li, Xiao-Ping Zhou, Zhen Li, Xiao-Chun Huang and Dan Li*. pH-induced formation of metalloligand: increasing structure dimensionality by tuning number of ligand functional sites. Chem.Comm., 2007, 3479.
11.Wen-Xiu Ni, Mian Li, Shun-Ze Zhan, Jin-Zhang Hou and Dan Li*. In Situ Immobilization of Metalloligands: A Synthetic Route to Homometallic Mixed-Valence Coordination Polymers. Inorganic chemistry, 2009, 48, 1433.
12.Zhou Lu, Yu-Jie Yang, Wen-Xiu Ni, Mian Li, Yifang Zhao, Yong-Liang Huang, Dong Luo, Xiaoping Wang, Mohammad A. Omary* and Dan Li*. Aggregation-induced phosphorescence sensitization in two heptanuclear and decanuclear gold–silver sandwich clusters. Chem. Sci., 2020, DOI: 10.1039/d0sc05095d.
13.Xiao-Ping Zhou, Wen-Xiu Ni, Shun-Ze Zhan, Jia Ni, Dan Li* and Ye-Gao Yin*, From Encapsulation to Polypseudo-rotaxane: Unusual Anion Networks Driven by Pre-designed Bis-Terpyridine Metal Complex Cations Inorganic chemistry, 2007, 46, 2345.
14.SC Tam，YH Cheng，CN Lok，HY Au-Yeung，WX Ni，XL Wei，KM Ng. Surface optimization of gold nanoparticle mass tags for the sensitive detection of protein biomarkers via immuno-capture LI-MS. ANALYST，2020,19，6237-6242.
15.RWY Sun, RF Xu, HQ Song, C Saint-Germain, M Zhang, WX Ni, CX Chen, C Hemmert, H Gornitzka, D Li. A gold(I)-pyrazolato complex as a switch-on luminescent probe for cysteine: in situ formation of fluorescent nanoparticles and rose-like microspheres. INORGANIC CHEMISTRY FRONTIERS,2016,11,1406-1410.
16.美国专利："Nitridoosmium(VI) Complexes for Treatment of Cancer", Tai-Chu Lau, Yun-Wah Lam, Wai-Lun man, Wen-Xiu Ni and Chi-Ming Che, Patent No.: US 8,383,673 B2, Date of Patent: Feb. 26, 2013.
曾小耘副教授：
1.血管内皮中KLF2的表观遗传修饰调控[J].四川生理科学杂志,2020,42(03):357-361.
2.子宫来源的前列腺素D2对妊娠母体血管舒缩功能的调控及在子痫前期状态下的作用与分
子机制（82070506），国家自然科学基金，55.00万元，2021.01-2024.12
黄永亮副教授：
1.国家自然科学基金青年科学基金，21801095，基于多酸配体生物金属有机框架的构筑、主客体识别及生物应用研究，2019.01-2021.12，24万，已结题，主持。
2.第62批中国博士后科学基金面上资助二等资助，基于多酸配体生物金属有机框架的构筑、载药及抗癌研究，2018.01-2019.12，5万，已结题，主持。
3．广东省科技专项资金项目，STKJ2021172，生物金属有机框架材料的构筑、小分子识别及药物负载应用研究， 2021.09-2024.08，4万，在研，主持。
4. 广东省科学技术厅，广东省基础与应用基础研究青年提升项目，2023A1515030234，生物金属有机框架材料的构筑、小分子识别及药物负载应用研究， 2023.01-2025.12，30万，在研，主持。
5.Exclusive Recognition of Acetone in a Luminescent BioMOF through Multiple Hydrogen-Bonding Interactions, Yong-Liang Huang, Pei-Li Qiu, Jian-Ping Bai, Dong Luo, Weigang Lu*, and Dan Li*, Inorg. Chem. 2019, 58, 7667-7671.
6.Reversible Multiphase Transition in a BioMOF and Its Distinctive Luminescence Turn-On in Alcohol Vapor, Jian-Ping Bai#, Yong-Liang Huang#, Mo Xie, Yifang Zhao, Dong Luo, Yan Yan Li, Weigang Lu*, and Dan Li*, ACS Appl. Mater. Interfaces 2019, 11, 38503−38509.
7.Tuning the C2/C1 Hydrocarbon Separation Performance in a BioMOF by Surface Functionalization, Yong-Liang Huang, Pei-Li Qiu, Heng Zeng, Huan Liu, Dong Luo, Yan Yan Li, Weigang Lu,* and Dan Li*, Eur. J. Inorg. Chem. 2019, 39-40, 4205-4210
8.Biological metal–organic frameworks: Structures, host–guest chemistry and bio-applications Hong Cai, Yong-Liang Huang, Dan Li*, Coord. Chem. Rev. 2019, 378, 207-221.
9.Induced Fit of C2H2 in a Flexible MOF Through Cooperative Action of Open Metal Sites, Heng Zeng, Mo Xie, Yong-Liang Huang, Yifang Zhao, Xiao-Jing Xie, Jian-Ping Bai, Meng-Yan Wan, Rajamani Krishna, Weigang Lu and Dan Li*, Angew. Chem. Int. Ed. 2019, 58, 8515-8519.
10.A pair of homochiral complexes generated via spontaneous resolution:Synthesis, structures and dielectric properties, Xiao-Dan Zheng, * Yong-Liang Huang, Yi-Ping Tong, Inorg. Chim. Acta, 2018, 482, 454-459.
11.Two Li-Zn Cluster-Based Metal-Organic Frameworks: Strong H2/CO2 Binding and High Selectivity to CO2, Yong-Liang Huang, Di-Chang Zhong, Long Jiang, Yun-Nan Gong, Tong-Bu Lu* , Inorg. Chem. 2017, 56, 705-708.
12.A facile method for the synthesis of a porous cobalt oxide–carbon hybrid as a highly efficient water oxidation catalyst, Mei Zhang, Yong-Liang Huang, Jia-Wei Wang and Tong-Bu Lu*, J. Mater. Chem. A 2016, 4, 1819-1827.
13.A unique magnesium-based 3D MOF with nanoscale cages and temperature dependent selective gas sorption properties, Yong-Liang Huang, Yun-Nan Gong, Long Jiang and Tong-Bu Lu*, Chem. Commun. 2013, 49, 1753-1755.
罗朝生教授：
1.Luo, C.; Bandar, J. S., Selective defluoroallylation of trifluoromethylarenes. J. Am. Chem. Soc. 2019, 141, 14120 – 14125.
2.Luo, C.#; Alegre-Requena, J. V. #; Pajk, S.; Sujansky, S.; Paton, R. S.; Bandar, J. S., Mechanistic Studies Yield Improved Protocols for Base-Catalyzed Anti-Markovnikov Alcohol Addition Reactions,
J. Am. Chem. Soc. 2022, 144, 9586–9596.
3.Luo, C.; Bandar, J. S., Superbase-catalyzed anti-Markovnikov alcohol addition reactions to aryl alkenes. J. Am. Chem. Soc. 2018, 140, 3547 – 3550.
4.Luo, C.; Wang, Z.; Huang, Y., Asymmetric intramolecular α-cyclopropanation of aldehydes using a donor/acceptor carbene mimetic. Nature Commun. 2015, 6, 10041.
5.Luo, C.; Huang, Y., A highly diastereo- and enantioselective synthesis of tetrahydroquinolines: quaternary stereogenic center inversion and functionalization. J. Am. Chem. Soc. 2013, 135, 8193 – 8196.
6.Luo, C.; Bandar, J. S., Synthesis of -phenethyl ethers via base-catalyzed alcohol addition reactions to aryl alkenes. Synlett, 2018, 29, 2218 – 2224. (invited)
7.Cooper, J. C.; Luo, C.; Kameyama, R.; van Humbeck, J. F., Dual catalytic system for site selective oxidation adjacent to azaheterocycles. J. Am. Chem. Soc. 2018, 140, 1243 – 1246.
8.Liu, X.; Long, M. J. C.; Hopkins, B. D.; Luo, C.; Wang, L.; Aye, Y. Precision targeting of pten-null triple-negative breast tumors guided by electrophilic metabolite sensing. ACS Cent. Sci. 2020, 6, 6, 892 – 902.
